Eagle Pharmaceuticals Inc/ US2697961082 /
| 09/09/2024 22:00:00 | Chg. - | Volume | Bid15:40:14 | Ask15:40:14 | High | Low |
|---|---|---|---|---|---|---|
| 3.9000USD | - | 97,307 Turnover: 311,660.6370 |
3.9000Bid Size: 400 | 4.0000Ask Size: 100 | 4.2800 | 3.9000 |
GlobeNewswire
25/06
Aldeyra, Eagle Pharmaceuticals, Blue Ridge Bankshares, and Amplitude Investigation Alert: Johnson Fi...
GlobeNewswire
13/06
Investigation Alert: Aldeyra, Eagle Pharmaceuticals, and Blue Ridge Bankshares: Johnson Fistel, LLP ...
GlobeNewswire
03/06
Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities
GlobeNewswire
15/05
Investigation Alert Baxter International, Eagle Pharmaceuticals, BioXcel Therapeutics, and ImmunityB...
GlobeNewswire
30/04
Eagle Pharmaceuticals Announces a Trial in Progress Presentation of Phase 2/3 Study of Intravenous A...
GlobeNewswire
15/04
Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Respon...
GlobeNewswire
12/04
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirem...
GlobeNewswire
11/02
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Eagle Pharmaceu...
GlobeNewswire
09/02
EGRX DEADLINE TOMORROW: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. ...
GlobeNewswire
08/02
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc.(EGRX) Investors of a Class ...
GlobeNewswire
08/02
EAGLE PHARMACEUTICALS 48 HOUR DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (J...
GlobeNewswire
08/02
EGRX FINAL DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Eagle Pharmaceuticals...
GlobeNewswire
05/02
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc.(EGRX) Investors of a Class ...
GlobeNewswire
05/02
DEADLINE ALERT for GM, EGRX, MRCY, and ON: The Law Offices of Frank R. Cruz Reminds Investors of Cla...
GlobeNewswire
05/02
DEADLINE ALERT for EGRX, ON, MRCY, LOVE: Law Offices of Howard G. Smith Reminds Investors of Class A...
GlobeNewswire
05/02
Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on...
GlobeNewswire
05/02
Holzer & Holzer, LLC Reminds Investors of February 9, 2024 Lead Plaintiff Deadline in Eagle Pharmace...
GlobeNewswire
05/02
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Eag...
GlobeNewswire
04/02
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Be...
GlobeNewswire
03/02
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Eagle Pharmaceu...
GlobeNewswire
02/02
ROSEN, A LEADING LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before...
